Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling by Jian Gao, Jifen Hu, Fang Yu, Chunlin Wang, Danmei Sheng, Wuling Liu, Anling Hu, Kunling Yu, Xiao Xiao, Yi Kuang, Eldad Zacksenhaus, Babu Gajendran, Yaacov Ben-David

Get full text